EAHAD statement on the ISTH clinical practice guideline for treatment of congenital haemophilia A and B

Authors: Chowdary, P; Álvarez-Román, MT; Baghaei, F; Klamroth, R; Miesbach, W; Blatny, J

Affiliations: Katherine Dormandy Haemophilia Centre, Royal Free London NHS Foundation Trust, London, UK. Haemostasis Unit, Instituto de Investigacion Hospital Universitario La Paz, Madrid, Spain. Department of Medicine, Vastra Gotalandsregionen Regionstyrelsen, Vanersborg, Sweden. Department of Internal Medicine, Vascular Medicine and Coagulation Disorders, Vivantes Klinikum im Friedrichshain, Berlin, Germany. Department of Haemostaseology, Goethe-Universitat Frankfurt am Main Universitatsklinikum Frankfurt, Frankfurt, Germany. Department of Paediatric Haematology and Biochemistry”, Masarykova univerzita Lekarska fakulta, Brno, Czech Republic.

Publication: Haemophilia; 2024

Abstract: The European Association for Haemophilia and Allied Disorders (EAHAD) commends the International Society’s on Thrombosis and Haemostasis (ISTH) initiative to publish evidence-based guidelines.1 These guidelines have been subject to considerable discussion, with numerous clinicians and organizations expressing concerns, and we acknowledge the disquiet within the wider community.2 Nevertheless, it is crucial to remember that guidelines are recommendations only, and their applicability should be carefully considered at both local and national levels.